Literature DB >> 11669499

Genetics of Epstein-Barr virus infection.

A Hiraki1, N Fujii, K Masuda, K Ikeda, M Tanimoto.   

Abstract

Epstein-Barr (EBV) virus is a member of the human herpesvirus family. EBV is the etiologic agent of acute infectious mononucleosis and is closely associated with the genesis of Burkitt's lymphoma and undifferentiated nasopharyngeal carcinoma. EBV is also implicated in a variety of other diseases, such as X-linked lymphoproliferative syndrome, T-cell non-Hodgkin's lymphoma, Hodgkin's disease, and NK-cell granular lymphoproliferative disorder. Recently, lymphoepithelial carcinoma of the stomach, gastric carcinoma, pyothorax-associated lymphoma, and smooth muscle tumors were also recognized as EBV-associated diseases. It is therefore important to review the genetics and immunological response of EBV infection. In this review we summarize the genetics of EBV, immunological responses and clinical findings of EBV-associated diseases, which would help us to understand the pathophysiology of EBV-associated disease and develop specific treatments.

Entities:  

Mesh:

Year:  2001        PMID: 11669499     DOI: 10.1016/s0753-3322(01)00084-1

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  Biogenesis of Epstein-Barr virus microRNAs.

Authors:  Do Nyun Kim; Suk Kyeong Lee
Journal:  Mol Cell Biochem       Date:  2012-02-18       Impact factor: 3.396

2.  Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma.

Authors:  Chi-Chao Chan; Defen Shen; Manabu Mochizuki; John A Gonzales; Hunter K L Yuen; Yan Guex-Crosier; Phuc Lehoang
Journal:  Trans Am Ophthalmol Soc       Date:  2006

3.  Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.

Authors:  Lassad Oussaief; Ali Fendri; Béatrice Chane-Woon-Ming; Remy Poirey; Henri-Jacques Delecluse; Irène Joab; Sébastien Pfeffer
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.